100% tevredenheidsgarantie Direct beschikbaar na betaling Zowel online als in PDF Je zit nergens aan vast
logo-home
NR 325 - FINAL EXAM STUDY GUIDE, (Answered) Complete Verified Solution, Over 280 Questions Ans Correct Answers $11.49   In winkelwagen

Tentamen (uitwerkingen)

NR 325 - FINAL EXAM STUDY GUIDE, (Answered) Complete Verified Solution, Over 280 Questions Ans Correct Answers

 2 keer bekeken  0 keer verkocht
  • Vak
  • Instelling

NR 325 - FINAL EXAM STUDY GUIDE, (Answered) Complete Verified Solution, Over 280 Questions Ans Correct Answers BREAST CANCER SCREENING GUIDELINES regular screening mammography starting at age 45 years. Women aged 45 to 54 years should be screened annually. Women 55 years and older should ...

[Meer zien]

Voorbeeld 4 van de 37  pagina's

  • 11 juli 2023
  • 37
  • 2022/2023
  • Tentamen (uitwerkingen)
  • Vragen en antwoorden
avatar-seller
NR 325 - FINAL EXAM STUDY GUIDE, (Answered)
Complete Verified Solution, Over 280 Questions Ans
Correct Answers
BREAST CANCER SCREENING GUIDELINES
regular screening mammography starting at age 45 years.

Women aged 45 to 54 years should be screened annually.

Women 55 years and older should transition to biennial screening or have the
opportunity to continue screening annually.

continue screening mammography as long as overall health is good and life expectancy
is 10 years or longer
THE BREAST SELF-EXAMINATION
lie down and place one arm behind the head

use finger pads of three middle fingers of the other hand to feel for lumps

use overlapping dime-sized circular motions to feel the breast tissue

use three different levels of pressure

up-and-down vertical pattern is recommended

stand in a front a mirror; examine breasts for:
- shape
- size
- redness/scaliness
- dimpling (skin/nipple)
MASTITIS
inflammation of the breast

occurs in up to 10% of postpartum lactating mothers 2-4 weeks after birth
MASTITIS - CLINICAL MANIFESTATIONS
warm to touch

indurated/painful

often unilateral

most commonly caused by staphylococcus aureus
BEST TIME TO PERFORM SELF BREAST EXAM (BSE)

,Perform BSE at the end of the menstrual period

breast tenderness is less likely to occur
RISK FACTORS FOR BREAST CANCER
early menarche

late menopause

Age - at or older than 50 yrs

hormone use

Family history/Genetics

History of cancer (breast, colon, endometrial, ovarian)

First full term pregnancy after age 30

nulliparity (never given birth)

benign breast disease (atypical epithelial hyperplasia)

weight gain/obesity after menopause

exposure to ionizing radiation

alcohol consumption
ADVANTAGE OF FINE-NEEDLE ASPIRATION (FNA) BIOPSY
FNA is performed in outpatient settings

results are available within 24-48 hours

no incision required
BREAST LUMPS - ASSESSMENT
painless and fixed lumps suggest breast cancer/malignancy
HORMONE THERAPY (HT)
HT has been linked to increased risk for breast cancer; patient and HCP must
determine whether or not HT therapy is appropriate

Breast cancer incidence is increased in women using HT, independent of other risk
factors

HT increases the risk for both non-BRCA-associated cancer and BRCA-related cancers
CLASSIFICATION OF BREAST CANCER
based on tissue type

,based on invasiveness

based on hormone receptor and genetic status
CLASSIFICATION OF BREAST CANCER - BASED ON ON TISSUE TYPE
Ductal carcinoma (milk ducts)
- Medullary
- Tubular
- Colloid (mucinous)

Lobular carcinoma (milk-producing glands)

Other
- Inflammatory
- Paget's disease
- Phyllodes tumor
CLASSIFICATION OF BREAST CANCER - BASED ON INVASIVENESS
Noninvasive (In situ)
- ductal carcinoma in situ (DCIS)
- lobular carcinoma in situ (LCIS)

Invasive (spreads)
- invasive ductal carcinoma
- invasive lobular carinoma
CLASSIFICATION OF BREAST CANCER - BASEDON HORMONE RECEPTOR
STATUS/GENETIC STATUS
Estrogen and Progesterone Receptor Status
- Estrogen receptor positive
- Estrogen receptor negative
- Progesterone receptor positive
- Progesterone receptor negative

HER-2 Genetic Status
- HER-2 positive
- HER-2 negative
TRASTUZUMAB (HERCEPTIN) - THERAPEUTIC USE
this Rx is for the treatment of of tumors that have the HER-2 receptor
TRASTUZUMAB (HERCEPTIN) - ADVERSE EFFECT
this Rx can lead to ventricular dysfunction

patient is taught to self-monitor for symptoms of heart failure
TAMOXIFEN (NOLVADEX - THERAPEUTIC USE
this Rx is for the treatment of estogen-dependent breast tumors in premenopausal
women
ESTRADIOL - CAUTION
this Rx will increase the growth of estrogen-dependent tumors
RALOXIFENE - THERAPEUTIC USE

, this Rx is used to prevent breast cancer

this Rx IS NOT USED postmastectomy
RADICAL MASTECTOMY - POST OP NURSING CARE
patients are at increased risk for lymphedema and infection

therefore, NO BLOOD PRESSURES OR VENIPUNCTURES in the affected arm

signage should be posted at the bedside to help remind staff
RADICAL MASTECTOMY - PATIENT TEACHING
patients should avoid any activity that might injure the affected arm

analgesics can be used

exercises should be continued in order restore strength/ROM

affected arm should be elevate at or above the heart to improve ROM/function
SITES OF BREAST CANCER RECURRENCE/METASTASIS
LOCAL RECURRENCE
skin
chest wall

REGIONAL RECURRENCE
lymph nodes

DISTAL METASTASIS
skeletal
spinal cord
brain
pulmonary
liver
bone marrow
TNM SYSTEM OF STAGING & PROGNOSIS
T = tumor size

N = nodal involvement

M = metastasis
TUMOR SIZE AS PROGNOSTIC INDICATOR
the larger the tumor, the poorer the prognosis

well differentiated the tumors = less aggressive

poorly differentiated tumors = more aggressive
RECEPTOR-POSITIVE TUMORS

Voordelen van het kopen van samenvattingen bij Stuvia op een rij:

Verzekerd van kwaliteit door reviews

Verzekerd van kwaliteit door reviews

Stuvia-klanten hebben meer dan 700.000 samenvattingen beoordeeld. Zo weet je zeker dat je de beste documenten koopt!

Snel en makkelijk kopen

Snel en makkelijk kopen

Je betaalt supersnel en eenmalig met iDeal, creditcard of Stuvia-tegoed voor de samenvatting. Zonder lidmaatschap.

Focus op de essentie

Focus op de essentie

Samenvattingen worden geschreven voor en door anderen. Daarom zijn de samenvattingen altijd betrouwbaar en actueel. Zo kom je snel tot de kern!

Veelgestelde vragen

Wat krijg ik als ik dit document koop?

Je krijgt een PDF, die direct beschikbaar is na je aankoop. Het gekochte document is altijd, overal en oneindig toegankelijk via je profiel.

Tevredenheidsgarantie: hoe werkt dat?

Onze tevredenheidsgarantie zorgt ervoor dat je altijd een studiedocument vindt dat goed bij je past. Je vult een formulier in en onze klantenservice regelt de rest.

Van wie koop ik deze samenvatting?

Stuvia is een marktplaats, je koop dit document dus niet van ons, maar van verkoper LectDan. Stuvia faciliteert de betaling aan de verkoper.

Zit ik meteen vast aan een abonnement?

Nee, je koopt alleen deze samenvatting voor $11.49. Je zit daarna nergens aan vast.

Is Stuvia te vertrouwen?

4,6 sterren op Google & Trustpilot (+1000 reviews)

Afgelopen 30 dagen zijn er 67163 samenvattingen verkocht

Opgericht in 2010, al 14 jaar dé plek om samenvattingen te kopen

Start met verkopen

Laatst bekeken door jou


$11.49
  • (0)
  Kopen